https://www.selleckchem.com/pr....oducts/azaindole-1.h
s across care settings and has the potential to improve patient care; however, more co-design work is needed to enhance the intervention and its fidelity.BACKGROUND Osteoporosis is a highly prevalent disease identified by Dual Energy X-ray Absorptiometry (DEXA) that can be performed in an ambulatory (out-patient) or hospitalized population. We evaluated the use of baseline in-hospital DEXA screening to identify osteoporosis in ambulatory care and hospitalized patients; we also assessed specific risk factors for osteoporosis among th